title: Measuring methotrexate polyglutamates in red blood cells: a new LC-MS/MS-based method.
abstract: The folate antagonist methotrexate (MTX) is the anchor drug in the treatment of rheumatoid arthritis. The therapeutic effects of MTX are attributed to the intracellular levels of MTX, present in the cell as polyglutamates (MTXPGn). We developed a new liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS)-based assay to separately quantitate MTXPGn in red blood cells using stable-isotope-labelled internal standards. Samples were analyzed by LC-ESI-MS/MS using a Waters Acquity UPLC BEH C18 column with a 5-100% organic gradient of 10 mM ammonium bicarbonate (pH 10) and methanol. The analysis consisted of simple sample preparation and a 6-min run time. Detection was done using a Waters Acquity UPLC coupled to a Waters Quattro Premier XE with electrospray ionization operating in the positive ionization mode. Assay validation was performed following recent Food and Drug Administration guidelines. The method was linear from 1-1,000 nM for all MTXPGn (R(2) > 0.99). The coefficient of variation ranged from 1-4% for intraday precision and 6-15% for interday precision. Samples were stable for at least 1 month at -80 °C. Recovery ranged from 98-100%, and the relative matrix-effect varied from 95-99%. The lower limit of quantitation was 1 nM for each MTXPGn. Fifty patient samples from the tREACH study were analyzed. The MTXPGn concentration and distribution of these samples were comparable with values reported in literature. The developed LC-ESI-MS/MS method for the quantitative measurement of MTXPGn in red blood cells is both sensitive and precise within the clinically relevant range. The method can be easily applied in clinical laboratories due to the combination of simple pre-treatment with robust LC-ESI-MS/MS.
authors.affiliation: Department of Clinical Chemistry, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands.
authors.forename: E
authors.initials: E
authors.lastname: den Boer
authors.forename: R J W
authors.initials: RJ
authors.lastname: Meesters
authors.forename: B D
authors.initials: BD
authors.lastname: van Zelst
authors.forename: T M
authors.initials: TM
authors.lastname: Luider
authors.forename: J M W
authors.initials: JM
authors.lastname: Hazes
authors.forename: S G
authors.initials: SG
authors.lastname: Heil
authors.forename: R
authors.initials: R
authors.lastname: de Jonge
mesh_terms: D018501:Antirheumatic Agents / Q000032:analysis / Q000097:blood*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D016903:Drug Monitoring / Q000379:methods*; D004912:Erythrocytes / Q000737:chemistry*; D006801:Humans; D057230:Limit of Detection; D008727:Methotrexate / Q000032:analysis / Q000097:blood*; D011099:Polyglutamic Acid / Q000032:analysis / Q000097:blood*; D012680:Sensitivity and Specificity; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods*; D053719:Tandem Mass Spectrometry / Q000379:methods
chemical_list: D018501:Antirheumatic Agents; D011099:Polyglutamic Acid; D008727:Methotrexate